Skip to content

Technology Assisted Treatment for Binge Eating Behavior

Technology Assisted Treatment for Binge Eating Behavior

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05829941
Enrollment
30
Registered
2023-04-26
Start date
2024-12-31
Completion date
2025-08-31
Last updated
2023-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge-Eating Disorder

Brief summary

Binge-eating behavior is a central feature of eating disorders (e.g., binge-eating disorder, bulimia nervosa, anorexia nervosa-binge-eating/purging subtype) and is associated with higher rates of psychopathology, psychosocial impairment, medical comorbidity, and more severe obesity, all of which pose significant public health problems. Passive detection of binge eating episodes combined with a context-based reminder intervention could assist a patient in resuming healthy eating patterns. This study will test a smartwatch app that identifies binge eating behavior and provides CBT strategies to the patient after the episode.

Interventions

BEHAVIORALSmartwatch app to deliver binge-eating CBT strategies

Participants will receive a smartwatch with a pre-loaded app that will alert the participant to relevant binge-eating strategies based on their previous detected behavior.

BEHAVIORALReminder control condition

Participants will receive a smartwatch that vibrates randomly, and will be instructed the vibration is a cue not to binge eat.

Sponsors

University of Minnesota
CollaboratorOTHER
HabitAware Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Adults ≥18 years of age 2. EDE diagnosis of bulimia nervosa or binge eating disorder, with binge-eating episodes occurring at least 2x/week

Exclusion criteria

1. Pregnancy or lactation 2. Acute medical or psychiatric risk 3. Psychosis or bipolar disorder (lifetime history) 4. Current substance use disorder within the past six months 5. BMI less than 18.5 kg/m2 6. Acute suicidality requiring hospitalization 7. Food allergies 8. Receiving current psychotherapy 9. On psychotropic medications that have not been on a stable dose for at least six weeks

Design outcomes

Primary

MeasureTime frameDescription
Percentage of patients in the HabitAware condition that report the treatment is acceptable.8 weeksMeasured via post-treatment survey

Secondary

MeasureTime frameDescription
Percentage of patients report that the binge episode detection is accurate8 weeksMeasured via post-treatment survey

Contacts

Primary ContactSameer Kumar, BS
sameer@habitaware.com2489904720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026